6.
Savarese G, Becher P, Lund L, Seferovic P, Rosano G, Coats A
. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2022; 118(17):3272-3287.
DOI: 10.1093/cvr/cvac013.
View
7.
Pitt B, Poole-Wilson P, Segal R, Martinez F, Dickstein K, Camm A
. Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: rationale, design, and baseline characteristics of patients in the Losartan Heart Failure Survival Study--ELITE II. J Card Fail. 1999; 5(2):146-54.
DOI: 10.1016/s1071-9164(99)90037-4.
View
8.
Abebe T, Gebreyohannes E, Tefera Y, Bhagavathula A, Erku D, Belachew S
. The prognosis of heart failure patients: Does sodium level play a significant role?. PLoS One. 2018; 13(11):e0207242.
PMC: 6224129.
DOI: 10.1371/journal.pone.0207242.
View
9.
Biegus J, Nawrocka-Millward S, Zymlinski R, Fudim M, Testani J, Marciniak D
. Distinct renin/aldosterone activity profiles correlate with renal function, natriuretic response, decongestive ability and prognosis in acute heart failure. Int J Cardiol. 2021; 345:54-60.
DOI: 10.1016/j.ijcard.2021.10.149.
View
10.
Dharmarajan K, Rich M
. Epidemiology, Pathophysiology, and Prognosis of Heart Failure in Older Adults. Heart Fail Clin. 2017; 13(3):417-426.
DOI: 10.1016/j.hfc.2017.02.001.
View
11.
Bettencourt P, Azevedo A, Pimenta J, Frioes F, Ferreira S, Ferreira A
. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation. 2004; 110(15):2168-74.
DOI: 10.1161/01.CIR.0000144310.04433.BE.
View
12.
McMurray J, Packer M, Desai A, Gong J, Lefkowitz M, Rizkala A
. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014; 371(11):993-1004.
DOI: 10.1056/NEJMoa1409077.
View
13.
Lin A, Chin J, Sicignano N, Evans A
. Repeat Hospitalizations Predict Mortality in Patients With Heart Failure. Mil Med. 2017; 182(9):e1932-e1937.
DOI: 10.7205/MILMED-D-17-00017.
View
14.
Daubert M, Yow E, Barnhart H, Pina I, Ahmad T, Leifer E
. Differences in NT-proBNP Response and Prognosis in Men and Women With Heart Failure With Reduced Ejection Fraction. J Am Heart Assoc. 2021; 10(10):e019712.
PMC: 8200692.
DOI: 10.1161/JAHA.120.019712.
View
15.
Yaku H, Seko Y, Kato T, Morimoto T, Kimura T
. Prognostic Implications of Residual Pleural Effusions at Discharge in Patients with Acute Decompensated Heart Failure. Eur J Intern Med. 2020; 85:133-135.
DOI: 10.1016/j.ejim.2020.11.023.
View
16.
Skott O, Briggs J
. Direct demonstration of macula densa-mediated renin secretion. Science. 1987; 237(4822):1618-20.
DOI: 10.1126/science.3306925.
View
17.
Hess G, Runkel S, Zdunek D, Hitzler W
. Reference interval determination for N-terminal-B-type natriuretic peptide (NT-proBNP): a study in blood donors. Clin Chim Acta. 2005; 360(1-2):187-93.
DOI: 10.1016/j.cccn.2005.04.031.
View
18.
Kobayashi M, Stienen S, Ter Maaten J, Dickstein K, Samani N, Lang C
. Clinical determinants and prognostic implications of renin and aldosterone in patients with symptomatic heart failure. ESC Heart Fail. 2020; 7(3):953-963.
PMC: 7261568.
DOI: 10.1002/ehf2.12634.
View
19.
Poletti R, Vergaro G, Zyw L, Prontera C, Passino C, Emdin M
. Prognostic value of plasma renin activity in heart failure patients with chronic kidney disease. Int J Cardiol. 2012; 167(3):711-5.
DOI: 10.1016/j.ijcard.2012.03.061.
View
20.
Kondo T, Yamada T, Tamaki S, Morita T, Furukawa Y, Iwasaki Y
. Serial Change in Serum Chloride During Hospitalization Could Predict Heart Failure Death in Acute Decompensated Heart Failure Patients. Circ J. 2018; 82(4):1041-1050.
DOI: 10.1253/circj.CJ-17-0938.
View